Skip to main content

Table 1 Association of AEG-1 expression with clinicopathological characteristics of PDAC patients

From: Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

Characteristics AEG-1 expression
  Low or none N (%) High N (%) Chi-square test, P-value
Gender Male 31 (29.52) 32 (30.48) 0.172
  Female 15 (14.29) 27 (25.71)  
Age (years) < 60 23 (21.90) 20 (19.05) 0.096
  ≥ 60 23 (21.90) 39 (37.15)  
Localization Head of the pancreas 28 (26.67) 46 (43.81) 0.057
  Body/tail of the pancreas 18 (17.14) 13 (12.38)  
Tumor size ≤ 2 10 (9.52) 4 (3.81) 0.025
  > 2 36 (34.29) 55 (52.38)  
Clinical Stage I 19 (18.10) 12 (11.43) 0.004
II 6 (5.71) 4 (3.81)
III 15 (14.29) 25 (23.81)
  IV 6 (5.71) 18 (17.14)  
T classification T1 10 (9.52) 4 (3.81) 0.006
T2 29 (27.62) 33 (31.43)
T3 3 (2.85) 11 (10.48)
  T4 4 (3.81) 11 (10.48)  
N classification N0 29 (27.62) 20 (19.05) 0.003
  N1 17 (16.19) 39 (37.14)  
M classification No 43 (40.95) 43 (40.95) 0.007
  Yes 3 (2.86) 16 (15.24)  
Histological Grades Well-differentiated 1 (0.95) 2 (1.90) 0.052
Moderately differentiated 40 (30.10) 45 (42.86)
  Poorly differentiated 4 (3.81) 13 (12.38)  
Histological Types Classical ductal adenocarcinoma 43 (40.95) 48 (45.73) 0.097
Adenosquamous carcinomas 2 (1.90) 5 (4.76)
Undifferentiated carcinomas 0 (1.00) 4 (3.81)
  Mixed ducal-neuroendocrine carcinoma 1 (0.95) 2 (1.90)  
Alcohol drinking No 24 (22.86) 40 (38.09) 0.104
  Yes 22 (20.95) 19 (18.10)  
Tobacco smoking No 28 (26.67) 28 (26.67) 0.172
Yes 18 (17.14) 31 (29.52)